{
    "Trade/Device Name(s)": [
        "T2Candida 1.1 Panel",
        "T2Candida QCheck",
        "T2Dx QCheck"
    ],
    "Submitter Information": "T2 Biosystems, Inc.",
    "510(k) Number": "K173536",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN140019"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PII"
    ],
    "Summary Letter Date": "November 13, 2017",
    "Summary Letter Received Date": "November 15, 2017",
    "Submission Date": "November 13, 2017",
    "Regulation Number(s)": [
        "21CFR866.3690"
    ],
    "Regulation Name(s)": [
        "Nucleic acid-based device for the amplification, detection, and identification of microbial pathogens directly from whole blood specimens"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "mycology"
    ],
    "Analyte(s)": [
        "Candida albicans",
        "Candida tropicalis",
        "Candida parapsilosis",
        "Candida glabrata",
        "Candida krusei"
    ],
    "Specimen Type(s)": [
        "Human whole blood"
    ],
    "Specimen Container(s)": [
        "K2EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "T2Dx Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "T2 Magnetic Resonance",
        "DNA amplification"
    ],
    "Methodologies": [
        "Magnetic resonance-based detection",
        "Species-specific amplicon detection"
    ],
    "Submission Type(s)": [
        "Panel",
        "Quality control material",
        "Cartridge",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for T2Candida 1.1 Panel using T2 Magnetic Resonance to detect five Candida species directly from human whole blood with updated cartridge design and workflow.",
    "Indications for Use Summary": "For the presumptive diagnosis of candidemia by direct qualitative detection and identification of five Candida species from EDTA human whole blood in patients with symptoms or risk for invasive fungal infection; performed independently of blood culture, requires concomitant cultures for susceptibility testing.",
    "fda_folder": "Microbiology"
}